KDM1A and nervous system disorder: Additionally, this EVOO-related secoiridoid has been shown to inhibit lysine-specific histone demethylase 1A (LSD1) also known as lysine (K)-specific demethylase 1A (KDM1A) a central epigenetic regulator of metabolic reprogramming in obesity-associated diseases, neurological disorders, and cancer [51].